Alpha Profiles · Company Profile

Viridian Therapeutics, Inc.\DE

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/viridian-therapeutics-inc-de

Entity: Public listing published
Primary listing: NASDAQ: VRDN
Verification: Partially verified
Last reviewed: 2026-09-20T04:45:51.509003+00:00

Overview

Alpha's canonical identity and public leadership record for Viridian Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

4 public records

Jennifer Tousignant

Named Executive Officer / Proxy

State: confirmed
Effective: From Apr 17, 2026
Confidence: 94%
Evidence: VRDN DEF 14A executive officersApr 17, 2026

Sean O. Mahoney

Named Executive Officer / Proxy

State: confirmed
Effective: From Apr 17, 2026
Confidence: 94%
Evidence: VRDN DEF 14A executive officersApr 17, 2026

Seth Harmon

Named Executive Officer / Proxy

State: confirmed
Effective: From Apr 17, 2026
Confidence: 94%
Evidence: VRDN DEF 14A executive officersApr 17, 2026

Thomas Beetham

Named Executive Officer

State: confirmed
Effective: From Apr 17, 2026
Confidence: 94%
Evidence: VRDN DEF 14A executive officersApr 17, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 20, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.